Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
Ramtin S, Ilyas A. Pharmaceutical considerations in treating neuropathic pain in athletes. Int Orthop. 2025 Apr; 49(4):951-958.
-
Martinazzi BJ, Monahan PF, Miltenberg B, Johns WL, Faasuamalie PE, Aynardi MC, Namdari S, Ciccotti MG. Preoperative Acute Depressive Episodes Are Associated With Increased Medication Prescribing and Inpatient Services After Primary Arthroscopic Rotator Cuff Repair. Arthroscopy. 2025 Aug; 41(8):2730-2737.e2.
-
McCurdy MA, Dalton J, Narayanan R, Herczeg CK, Baidya J, Dawes A, Melendez M, Goldberg M, Wright J, Kaye ID, Woods B, Cha T, Canseco JA, Hilibrand AS, Vaccaro AR, Schroeder GD, Kepler CK. Perioperative Antidepressant Use is Associated With Symptomatic Pseudarthrosis After Lumbar Fusion. Spine (Phila Pa 1976). 2025 Aug 15; 50(16):1139-1144.
-
McCurdy M, Narayanan R, Dalton J, Herczeg CK, Heard J, Lee Y, Giakas A, Boyajieff E, Glover A, Sumughan S, Bowen G, Dulitzki Y, Dean E, Kurd M, Canseco JA, Hilibrand AS, Vaccaro AR, Kepler CK, Schroeder GD. Impact of Antidepressant Use on Intraoperative Blood Loss and Transfusion Rates in Lumbar Fusion Surgery. World Neurosurg. 2025 02; 194:123413.
-
McIntyre RS, Sundararajan K, Behl S, Hefting N, Jin N, Brewer C, Hobart M, Thase ME. A double-blind, placebo-controlled, randomised withdrawal study of adjunctive brexpiprazole maintenance treatment for major depressive disorder. Acta Neuropsychiatr. 2024 Oct 17; 37:e33.
-
Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte JE, Cross JT, Wilt TJ, Crandall CJ, Hicks LA, Balk EM, Cooney TG, Fitterman N, Lin JS, Maroto M, Miller MC, Obley AJ, Shekelle PG, Tice JA, Harrod CS, Yost J. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 2). Ann Intern Med. 2024 Aug; 177(8):e2400593.
-
Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte J, Cross JT, Wilt TJ, Crandall CJ, Balk E, Cooney TG, Fitterman N, Hicks LA, Lin JS, Maroto M, Obley AJ, Tice JA, Yost J. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med. 2023 02; 176(2):239-252.
-
Kutkat O, Moatasim Y, Al-Karmalawy AA, Abulkhair HS, Gomaa MR, El-Taweel AN, Abo Shama NM, GabAllah M, Mahmoud DB, Kayali G, Ali MA, Kandeil A, Mostafa A. Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies. Sci Rep. 2022 07 28; 12(1):12920.
-
Van den Eynde V, Abdelmoemin WR, Abraham MM, Amsterdam JD, Anderson IM, Andrade C, Baker GB, Beekman ATF, Berk M, Birkenh?ger TK, Blackwell BB, Blier P, Blom MBJ, Bodkin AJ, Cattaneo CI, Dantz B, Davidson J, Dunlop BW, Est?vez RF, Feinberg SS, Finberg JPM, Fochtmann LJ, Gotlib D, Holt A, Insel TR, Larsen JK, Mago R, Menkes DB, Meyer JM, Nutt DJ, Parker G, Rego MD, Richelson E, Ruh? HG, S?iz-Ruiz J, Stahl SM, Steele T, Thase ME, Ulrich S, van Balkom AJLM, Vieta E, Whyte I, Young AH, Gillman PK. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr. 2023 08; 28(4):427-440.
-
Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, Aslam M, Batki SL, Bjork JM, Blow FC, Brenner LA, Chen P, Desai S, Dieperink EW, Fears SC, Fuller MA, Goodman CS, Graham DP, Haas GL, Hamner MB, Helstrom AW, Hurley RA, Icardi MS, Jurjus GJ, Kilbourne AM, Kreyenbuhl J, Lache DJ, Lieske SP, Lynch JA, Meyer LJ, Montalvo C, Muralidhar S, Ostacher MJ, Paschall GY, Pfeiffer PN, Prieto S, Przygodzki RM, Ranganathan M, Rodriguez-Suarez MM, Roggenkamp H, Schichman SA, Schneeweis JS, Simonetti JA, Steinhauer SR, Suppes T, Umbert MA, Vassy JL, Voora D, Wiechers IR, Wood AE. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.